Læknablaðið - 15.04.2005, Síða 17

FRÆÐIGREINAR / MELTINGARSJÚKDÓMAR
4. Talley NJ, Schleck CD, Melton LJ. Dyspepsia and dyspepsia
subgroups: a population-based study. Gastroenterology 1992;
102: 1259-68.
5. Agreus L, Svardsudd K, Nyren O,Tibblin G. Irritable bowel syn-
drome and dyspepsia in the general population: overlap and
lack of stability over time. Gastroenterology 1995; 109: 671-80.
6. Heading RC. Prevalence of upper gastrointestinal symp-
toms in the general population: a systematic review. Scand J
Gastroenterol 1999; 34 Suppl 231: 3-8.
7. Stanghellini V. Three-Month Prevalence Rates of Gastrointes-
tinal Symptoms and the Influence of Demographic Factors:
Results from the Domestic/International Gastroenterology
Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 34
Suppl 231:20-8.
8. Enck P. Quality of Life in Patients with Upper Gastrointestinal
Symptoms: Results from the Domestic/International Gastro-
enterology Surveillance Study (DIGEST). Scand J Gastro-
enterol 1999; 34 Suppl 231: 48-54.
9. Haycox A.. The Health Economic Impact of Upper Gastro-
intestinal Symptoms in the General Population: Results from
the Domestic/Intemational Gastroenterology Surveillance
Study (DIGEST). Scand J Gastroenterol 1999; 34 Suppl 231:
38-47.
10. Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G,
Dapoigny M, Marshall JK, et al. Epidemiological aspects of
irritable bowel syndrome in Europe and North America.
Digestion 2001; 64:200-4.
11. Bennett EJ, Piesse C, Badcock CA, KellowJE. Level ofchronic
life stress predicts clinical outcome in irritable bowel syn-
drome. Gut 1998; 43: 256-61.
12. Talley NJ, Harmsen WS, Zinsmeister AR, Evans, RW. Medical
costs in community subjects with irritable bowel syndrome.
Gastroenterology 1995; 109:1736-41.
13. Hahn BA, Strassels S. Impact of irritable bowel syndrome on
quality of life and resource use in the United States and United
Kingdom. Digestion 1999; 60: 70-81.
14. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K,
Goodman C, et al. The burden of selected digestive diseases in
the United States. Gastroenterology 2002; 122:1500-11.
15. Camilleri M, Economic burden of irritable bowel syndrome.
Proposed strategies to control expenditures. Pharmacoeco-
nomics 2000; 17: 331-8.
16. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards
positive diagnosis of the irritable bowel. BMJ 1978; 2: 653-4.
17. Thompson WG, Drossman DA, Heaton, KW MG. Functional
bowel disease and functional abdominal pain. Gastroenterol
Int 1992; 5: 75-91.
18. Thompson WG, Drossman DA, Heaton KW, Kruis, W. Irritable
bowel syndrome: guidelines for the diagnosis. Gastroenterol
Int 1989; 2: 92-5.
19. Thompson WG, Longstreth GF, Drossman DA, Heaton KW,
Irvine EJ, Muller-Lissner SA. Functional bowel disorders and
functional abdominal pain. Gut 1999; 45 Suppl 2: II43-7.
20. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome
according to varying diagnostic criteria: are the new Rome II
criteria unnecessarily restrictive for research and practice? Am
J Gastroenterol 2000; 95: 3176-83.
21. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL,
Melton LJ, 3rd. A comparison of the Rome and Manning cri-
teria for case identification in epidemiological investigations of
irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2816-
24.
22. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M,
et al. Irritable bowel syndrome prevalence varies enormously
depending on the employed diagnostic criteria: comparison of
Rome II versus previous criteria in a general population. Scand
J Gastroenterol 2001; 36:1155-61.
23. Read NW. IBS—It All Depends Where You Draw the Line.
Scand J Gastroenterol 2001; 11: 1121-2.
24. Levy RL, Von Korff MR, Feld AD. Intergenerational transmis-
sion of gastrointestinal illness behavior. Am J Gastroenterol
Int 2000; 95:451-6.
25. Drossman DA, Sandler RS, Mitchell CM, Cramer EM,
Lowman BC. Psychosocial factors in the irritable bowel syn-
drome: a multivariate study of patients and non-patients with
irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
26. Whitehead WE, Palsson O, Jones KR. Systematic review of the
comorbidity of irritable bowel syndrome with other disorders:
what are the causes and implications? Gastroenterology 2002;
122:1140-56.
27. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ, 3rd.
Epidemiology of colonic symptoms and the irritable bowel
syndrome. Gastroenterology 1991; 101: 927-34.
28. Dillman D. Mail and Telephon Surveys. The total design
method. A Wiley-Interscience Publication. John Wiley and
Sons 1978.
29. Talley NJ, PhiIIips SF, Melton J, 3rd, Wiltgen C, Zinsmeister AR.
A patient questionnaire to identify bowel disease. Ann Intern
Med 1989; 111: 671-4.
30. Drossman DA. A questionnaire for functional bowel disorders.
Ann Intern Med 1989; 111: 627-9.
31. Talley NJ,SF Wiltgen, CM Zinsmeister, AR MeltonlII J.The
Bowel Disease Questionnaire. Mayo Clin Proc 1990; 65:1456-
79.
32. Talley NJ. Unnecessary abdominal and back surgery in irritable
bowel syndrome: time to stem the flood now? Gastroenterology
2004; 126:1899-903.
33. Ragnarsdóttir T, Steinþórsdóttir Á, Svavarsdóttir EK, Sigurös-
son JÁ, Steingrímsdóttir L, Pétursson P, et al. Áherslur til
heilsueflingar. Directorate of Health. Landlæknisembættiö.
Reykjavík. Iceland 2003.
34. European social statistics. Labour force survey results 2002.
COMMISSION THEME 3. Population and social conditions
2002.
35. Health Statistics in the Nordic Countries 2001. Nordisk medici-
nalstatistisk Komité, Köbenhavn 2003.
Læknablaðið 2005/91 333